In short
Elevance Health, Inc. (ELV) has revenue up 12.5% to $199.1B and net income down 5.3% to $5.7B year on year. Its net margin is 2.8%, and it trades at 19.2× trailing earnings. Fisclear found no medium- or high-severity risk flags in this filing. How we calculate this
Compare: ELV vs UNH · ELV vs HCA · ELV vs THC · CNC vs ELV
Valuation
HealthcareLive · Yahoo FinancePrice
$394.48
$85.2B
9.0x
1.74%
52-Week Range
Decision Context
The reverse DCF implies growth expectations well above historical averages. Fundamentals need to accelerate significantly to justify the current price. Consider the margin of safety before sizing a position.
Based on filing period ending Sept 2026
FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.
Macro Context
Fed Funds Rate
3.75%
Accommodative
10-Year Treasury
4.99%
2026-09-01
Unemployment
4.2%
Near full employment
CPI Index
336.3
2026-09-01
The Federal Funds rate stands at 3.75% — a moderately elevated rate environment that raises borrowing costs across the economy; 10-year Treasury yields are at 4.99%, setting the benchmark for long-term corporate borrowing; Unemployment stands at 4.2%; Industrial production index is at 104.0; CPI index stands at 336.3.
SWOT Analysis — ELV
Inflationary BoomStrengths
Revenue: $199.1B (+12.5% YoY) — Revenue grew 12% — the company sold more goods or services than the prior year.
Weaknesses
Operating Cash Flow: $4.3B (-26.1% YoY) — Operating cash flow fell 26% but remained positive.
Net Income: $5.7B (-5.3% YoY) — Profit fell 5% but remained positive.
EPS (Diluted): $25.21 (-1.8% YoY) — Earnings per share fell 2%.
Opportunities
Total Assets: $121.5B (+3.9% YoY) — Total assets grew 4% — the company's resource base expanded.
Threats
No significant threats flagged.
Year-over-Year Changes
Operating Cash Flow
$4.3B
was $5.8B
Operating cash flow fell 26% but remained positive.
Revenue
$199.1B
was $177.0B
Revenue grew 12% — the company sold more goods or services than the prior year.
Net Income
$5.7B
was $6.0B
Profit fell 5% but remained positive.
Total Assets
$121.5B
was $116.9B
Total assets grew 4% — the company's resource base expanded.
EPS (Diluted)
$25.21
was $25.68
Earnings per share fell 2%.
Technical Signals
Daily closes · 1-year dataElevance Health, Inc.: common questions
Is Elevance Health, Inc. profitable?
Yes. Elevance Health, Inc. made a net profit of $5.7B in its latest fiscal year (fiscal 2025), a net margin of 2.8%.
Is Elevance Health, Inc.'s revenue growing?
Yes. Revenue grew 12.5% year on year, to $199.1B.
What is Elevance Health, Inc.'s P/E ratio?
Elevance Health, Inc. trades at 16.8× its trailing twelve-month earnings. In other words, the share price is about 17 times the profit per share the company earned over the past year.
Does Elevance Health, Inc. pay a dividend?
Yes. Elevance Health, Inc.'s forward dividend yield is 1.74%, the expected annual dividend as a share of the current share price.
Answers are generated from the figures in this report (updated 21 Oct 2026). Information, not investment advice.
Latest News
via FinnhubFiling History — ELV
Get the weekly digest
5 company reports + macro context every week, free. No spam.
- Unlimited goal simulations
- 5 free company report summaries per day
- Weekly financial insights newsletter
External Links
Trade ELV
Links open broker research pages. Not an endorsement or recommendation.
Research Elevance Health, Inc.
Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.